Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Study Details
Study Description
Brief Summary
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
OUTLINE:
Patients complete a questionnaire at baseline (paper, online, or telephone-based) and medical records are reviewed.
Patients are then randomized to 1 of 2 arms.
ARM I: Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).
ARM II: Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care.
PRIMARY CARE PROVIDERS: Primary care providers complete a questionnaire about perceptions of the SCP and self-efficacy in providing survivorship care.
After completion of study, patients are followed up at approximately 8 weeks.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Arm I (patient-generated SCP) Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses). |
Other: Survivorship Care Plan
Receive patient-generated SCP
Other: Questionnaire Administration
Ancillary studies
|
Experimental: Arm II (patient-generated SCP, educational counseling) Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors. |
Other: Survivorship Care Plan
Receive patient-generated SCP
Other: Educational Intervention
Receive telephone-based educational counseling session
Other Names:
Other: Questionnaire Administration
Ancillary studies
|
Outcome Measures
Primary Outcome Measures
- Initial participation rate of cancer survivors identified from community-based practices [Up to 8 weeks]
- Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction [Up to 8 weeks]
Will measure the accuracy of participants' SCPs by comparing their self-reported medical history collected via questionnaire, with data abstracted from medical records. Accuracy will be reported by percentage of missing data in the self-generated SCP compared to medical records, and percentage of incorrect data in the self-generated SCP compared to medical records.
- Proportion of survivors who receive the phone-based education session within the study time period [Up to 8 weeks]
- Proportion of survivors who complete the follow-up questionnaire within the study time period [Up to 8 weeks]
- Response rate among primary care providers (PCPs) to the PCP survey [Up to 8 weeks]
Secondary Outcome Measures
- Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales [Up to 8 weeks]
The effects of the intervention versus (vs.) control on participant perceived self-efficacy will be measured at baseline and at the end of the study via a questionnaire using the PROMIS Global 10 and health related self-efficacy scales.
- Survivorship knowledge [Up to 8 weeks]
The effects of the intervention vs. control on survivorship knowledge will be measured at baseline and at the end of the study via a questionnaire.
- PCP self-efficacy towards survivorship care [Up to 8 weeks]
The effects of the intervention vs. control on PCP self-efficacy towards survivorship care will be measured at baseline and at the end of the study via a questionnaire using the PROMIS Global 10 and health related self-efficacy scales.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
-
History of either adult-onset (age >= 18) lymphoma, breast, colorectal, lung, or prostate cancer
-
Able to perform all study requirements, including responding to questionnaires
-
Willing to be randomized
-
Capable of providing informed consent
-
Consent to release oncology and primary care medical records
-
English or Spanish speakers
-
PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants at Washington, Wyoming, Alaska, Montana and Idaho-region Practice and Research Network (WPRN) clinics will be contacted about participating in the study after participant enrollment into the study.
Exclusion Criteria:
-
Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
-
Lacks telephone access
-
Lacks mailing address or ability to receive study materials electronically
-
Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
-
History of having had > 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | United States | 98109 |
Sponsors and Collaborators
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Eric Chow, Fred Hutch/University of Washington Cancer Consortium
Study Documents (Full-Text)
More Information
Publications
None provided.- RG1005815
- NCI-2019-05726
- 10267
- P30CA015704
- R21CA258105